Navigation Links
LSUHSC researchers working to prevent diabetic neuropathy
Date:9/22/2009

New Orleans, LA Dennis Paul, PhD, Associate Professor of Pharmacology, and Harry Gould, MD, PhD, the Tom Benson Professor of Neurology at LSU Health Sciences Center New Orleans, have been awarded one of two scientific research grants made in 2009 by The Neuropathy Association. The $80,000 grant will fund research to learn how to prevent nerve cell death in people with uncontrolled or untreated diabetes resulting in neuropathy.

In these patients, an enzyme called sodium potassium ATPase, know as the sodium pump because it pumps excess sodium ions out of the cell, does not work. When inflammation occurs, it triggers an increase in the number and sensitivity of sodium channels in the nerve cell membrane causing an influx of sodium with no way to get rid of it. Water follows the sodium into the nerve cells, causing swelling until the cells burst, a process called lysis.

Drs. Paul and Gould believe that by studying the role of nerve cell death by lysis, they can contribute a better understanding of how diabetic neuropathy develops, leading to better ways to influence the process.

"Understanding the mechanism of nerve cell survival after inflammatory or neuropathic insult will lead to new treatment and prevention strategies for diabetic neuropathy," says Dr. Paul.

The LSUHSC research team was chosen from thirteen applicants involved in neuropathy research at medical institutions across North America.

"We continue to invest in critical research that builds on our understanding of neuropathy's many forms, hopeful that our investments will lead to more effective treatment options and cures," says Thomas H. Brannagan, III, MD, Medical Advisor for The Neuropathy Association.


'/>"/>

Contact: Leslie Capo
lcapo@lsuhsc.edu
504-568-4806
Louisiana State University Health Sciences Center
Source:Eurekalert

Page: 1

Related biology news :

1. LSUHSC awarded $10M+ COBRE grant
2. LSUHSCs Lazartigues awarded $1.2 million grant
3. LSUHSC research reports new method to protect brain cells from diseases like Alzheimers
4. LSUHSC awarded patent for compound inhibiting cancer and other diseases
5. LSUHSC research identifies key contributor to Alzheimers disease process
6. LSUHSC student awarded top national honor for diabetes research
7. LSUHSC public health researcher finds reason for weight gain
8. LSUHSC research describes function of key protein in cancer spread
9. LSUHSCs Kolls awarded $1.8 million to improve vaccine strategies for P. carinii pneumonia
10. LSUHSC research helps link schizophrenia to specific DNA region
11. LSUHSCs Bazan awarded ARRA grant to preserve vision
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/11/2017)... , Jan. 11, 2017 Intoxalock, a leading ... the release of its patent-pending calibration device. With this ... perform calibrations, securely upload data logs and process repairs ... customer. "Fighting drunk driving through the application ... public at large, but also for the customer who ...
(Date:1/6/2017)... 2017  Privately-held CalciMedica, Inc., announced that it ... of a novel calcium release-activated calcium (CRAC) channel ... Acute pancreatitis, sudden painful inflammation of ... can be very serious.  In severe cases it can ... hospital stays, time in the ICU and substantial ...
(Date:1/6/2017)... 2017  Delta ID Inc., a leader in consumer-grade ... automotive at CESĀ® 2017. Delta ID has collaborated with ... the use of iris scanning as a secure, reliable ... in a car, and as a way to elevate ... Delta ID and Gentex will demonstrate (booth #7326 ...
Breaking Biology News(10 mins):
(Date:1/19/2017)... Jan. 19, 2017 /PRNewswire -- WuXi AppTec, a ... capability and technology platform, today announced that it ... focused preclinical drug discovery contract research organization (CRO). ... a wholly-owned subsidiary of WuXi, and will continue ... providing greater services. The acquisition will further strengthen ...
(Date:1/19/2017)... Jan. 19, 2017  ArmaGen, Inc., today announced ... Ph.D., as chief executive officer, as well as ... brings to ArmaGen more than 17 years of ... development of biotherapeutics and pharmaceuticals. ... diverse experience and skillset necessary to lead ArmaGen ...
(Date:1/19/2017)... ... January 19, 2017 , ... DaVita ... full spectrum of drug and device development, and Prism Clinical Research , ... clinicians, today announced Verified Clinical Trials (VCT) has been selected by ...
(Date:1/18/2017)... ... January 18, 2017 , ... ... device-to-computer interconnect using USB or PCI Express, announced the ZEM5310 USB 3.0 FPGA ... FPGA into a compact business-card sized form factor suitable for prototyping, testing, and ...
Breaking Biology Technology: